Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q1 2025 Earnings Call Transcript May 15, 2025
Taysha Gene Therapies, Inc. reports earnings inline with expectations. Reported EPS is $-0.08 EPS, expectations were $-0.08.
Operator: Greetings, and welcome to the Taysha Gene Therapies First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is...
